The CSC population, characterized with the cellular identity CD44+/CD24−/lowLin−ALDH-1+ and the capacity to recapitulate the phenotypic heterogeneity of the primary tumour when injected into secondary NOD/SCID mice [6,165], has been demonstrated to display active Hh signaling to maintain stemness potential. This evidence concerns the gene CD44 and neoplasm.